Please login to the form below

Not currently logged in
Email:
Password:

Medicxi

This page shows the latest Medicxi news and features for those working in and with pharma, biotech and healthcare.

Novartis and J&J back latest €400m Medicxi biopharma fund

Novartis and J&J back latest €400m Medicxi biopharma fund

to Medicxi, with European companies growing in stature and offering improved returns on investment for backers. ... to the US, Medicxi’s co-founder Francesco De Rubertis told the Financial Times.

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Medicxi appoints former GSK chair Moncef Slaoui Medicxi appoints former GSK chair Moncef Slaoui

    He joins the life science investment firm as a partner. London, UK-based life science investment group Medicxi has appointed former GSK chairman of pharmaceutical R&D, vaccines Dr Moncef Slaoui ... He said: “Having developed a strong relationship with

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics